- Home
- SPG vs TAK Comparison
SPG vs TAK Comparison
Compare SPG & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPG
- TAK
- Stock Information
- Founded
- SPG 1960
- TAK 1781
- Country
- SPG United States
- TAK Japan
- Employees
- SPG N/A
- TAK N/A
- Industry
- SPG Real Estate Investment Trusts
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- SPG Real Estate
- TAK Health Care
- Exchange
- SPG Nasdaq
- TAK Nasdaq
- Market Cap
- SPG 52.8B
- TAK 47.5B
- IPO Year
- SPG 1993
- TAK N/A
- Fundamental
- Price
- SPG $172.19
- TAK $14.81
- Analyst Decision
- SPG Buy
- TAK
- Analyst Count
- SPG 11
- TAK 0
- Target Price
- SPG $182.09
- TAK N/A
- AVG Volume (30 Days)
- SPG 1.4M
- TAK 5.5M
- Earning Date
- SPG 08-04-2025
- TAK 07-30-2025
- Dividend Yield
- SPG 4.99%
- TAK 3.67%
- EPS Growth
- SPG N/A
- TAK N/A
- EPS
- SPG 6.47
- TAK 0.59
- Revenue
- SPG $6,034,414,000.00
- TAK $31,053,301,865.00
- Revenue This Year
- SPG N/A
- TAK $0.47
- Revenue Next Year
- SPG $3.34
- TAK $0.80
- P/E Ratio
- SPG $26.60
- TAK $25.03
- Revenue Growth
- SPG 3.34
- TAK 1.52
- 52 Week Low
- SPG $136.34
- TAK $12.80
- 52 Week High
- SPG $190.14
- TAK $15.53
- Technical
- Relative Strength Index (RSI)
- SPG 62.80
- TAK 57.29
- Support Level
- SPG $163.29
- TAK $13.49
- Resistance Level
- SPG $172.88
- TAK $14.29
- Average True Range (ATR)
- SPG 3.72
- TAK 0.20
- MACD
- SPG 0.60
- TAK 0.09
- Stochastic Oscillator
- SPG 94.76
- TAK 99.22
About SPG Simon Property Group Inc.
Simon Property Group is the largest retail real estate investment trust in the United States. Its portfolio includes an interest in 232 properties: 134 traditional malls, 73 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $733 in sales per square foot over the trailing 12 months. The company also owns a 22% interest in Klépierre, a European retail company with investments in shopping centers in 14 countries, and joint-venture interests in 33 premium outlets across 11 countries.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.